Astonea Labs Stock Screener | Share Price & Fundamental Analysis

ASTONEALAB Pharmaceuticals
Track Astonea Labs share price live with TickJournal's free stock screener. Analyze Astonea Labs share price history trends and compare 52-week high low levels. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Astonea Labs Market Cap ₹167.80 Cr.
ASTONEALAB P/E Ratio (TTM) -
Astonea Labs P/B Ratio 2.99
EPS (TTM) ₹6.94
Dividend Yield -
Debt to Equity 3.16
ASTONEALAB 52 Week High -
Astonea Labs 52 Week Low -
Operating Margin -
Profit Margin -
ASTONEALAB Revenue (TTM) -
EBITDA -
Net Income -
Total Assets ₹103.00
Total Equity ₹18.00

Astonea Labs Share Price History - Stock Screener Chart

Screen ASTONEALAB historical share price movements with interactive charts. Analyze price trends and patterns.

Astonea Labs Company Profile - Fundamental Screener

Screen Astonea Labs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ASTONEALAB shares.
Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E
ISIN INE0TG901011

Astonea Labs Balance Sheet Screener

Screen ASTONEALAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022
Assets
Total Assets 103 81 64 53
Current Assets 71 55 43 31
Fixed Assets 25 22 21 21
Liabilities
Total Liabilities 0 0 0 0
Current Liabilities 22 21 20 23
Non-Current Liabilities 0 0 0 0
Shareholders' Equity
Total Equity 18 12 8 8
Share Capital 8 8 4 4
Reserves & Surplus 11 4 4 4

Astonea Labs Income Statement Screener - Profit & Revenue Analysis

Screen Astonea Labs income statement and profit fundamentals. Analyze ASTONEALAB quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Astonea Labs share price evaluation.
Item None-None 2025-March 2024-March 2023-March 2022-March
Revenue 0 98 80 67 30
Expenses 0 82 68 60 24
EBITDA 0 15 12 7 6
Operating Profit % 0.00% 16.00% 15.00% 11.00% 19.00%
Depreciation 0 5 4 4 4
Interest 0 4 3 2 2
Profit Before Tax 0 7 5 1 1
Tax 0 2 1 0 0
Net Profit 0 5 4 1 0
EPS 0.00 6.94 5.36 0.88 0.33

Astonea Labs Cash Flow Screener - Liquidity Fundamentals

Screen ASTONEALAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March
Operating Activities 9 8 -1 -5
Investing Activities -11 -8 -3 -3
Financing Activities 2 0 4 8
Net Cash Flow 0 -1 0 0

Astonea Labs Shareholding Pattern Screener

See Astonea Labs shareholding pattern with promoter, FII, and DII holdings. Check Astonea Labs promoter holding and ownership changes for ASTONEALAB on TickJournal.
Item 2025-Sept 2025-Jun 2025-May 2024-Aug
Promoter Holding 72.30% 72.30% 72.30% 98.43%
FII Holding 2.51% 8.01% 0.00% 0.00%
DII Holding 0.35% 4.55% 0.00% 0.00%
Govt Holding 0.00% 0.00% 0.00% 0.00%
Public Holding 17.06% 11.51% 12.24% 0.00%
Other Holding 7.77% 3.62% 15.45% 1.57%
Shareholder Count 437 1,014 36 36

Astonea Labs Share Dividend Screener - Share Yield Analysis

Check Astonea Labs dividend history with payout and yield data. View Astonea Labs dividend details including ex-dates and amounts for ASTONEALAB stock.
No dividends declared by Astonea Labs.

Astonea Labs Stock Index Membership

See which indices include Astonea Labs stock. Check ASTONEALAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE SME IPO

Astonea Labs Market Events Screener - Corporate Actions

Get Astonea Labs corporate actions including splits, bonuses, and buybacks. Check Astonea Labs stock events that may affect ASTONEALAB share price.
Announcement Date Record Date Event Type Information Price Impact
2025-12-27 2025-12-27 Annual General Meeting NA 6.70%
2025-11-10 2025-11-10 Quarterly Result Announcement NA 2.50%
2025-07-11 2025-07-11 Quarterly Result Announcement NA 3.94%

Astonea Labs Competitors Screener - Peer Comparison

Screen ASTONEALAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 406,351 37.86 54,729 9.71% 10,980 37.98
Divis Laboratories 155,472 63.26 9,712 18.67% 2,191 33.24
Torrent Pharmaceuticals 134,945 61.20 11,539 6.99% 1,911 32.75
Lupin 103,954 22.26 22,910 13.74% 3,306 47.35
Dr Reddys Laboratories 101,601 18.27 33,741 16.73% 5,725 39.36
Cipla 96,320 21.31 28,410 7.12% 5,291 26.86
Zydus Life Science 86,964 17.29 23,511 18.55% 4,615 41.42
Mankind Pharma 82,499 45.81 12,744 20.90% 2,007 41.40
Aurobindo Pharma 77,462 22.37 32,346 9.43% 3,484 64.38
Alkem Laboratories 62,867 25.87 13,458 3.70% 2,216 42.54

Astonea Labs Company Announcements - News Screener

Screen ASTONEALAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-04-04 Announcement under Regulation 30 (LODR)-Acquisition -
2026-03-31 Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association -
2026-03-31 Approval Of Variation In The Objects Of The Initial Public Offer (IPO) -
2026-03-31 Shareholder Meeting / Postal Ballot-Scrutinizer"s Report -
2026-03-31 Shareholder Meeting / Postal Ballot-Outcome of EGM -
2026-03-30 Closure of Trading Window -
2026-03-03 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-03-02 Notice Of Extra-Ordinary General Meeting Of Astonea Labs Limited -
2026-02-27 Board Meeting Outcome for For Meeting Held On 27Th February 2026 -
2026-02-24 Board Meeting Intimation for Consideration And Approval For Variation In The Objects Of The Initial Public Offer (IPO) And Others. -
2026-02-13 Acquisition Of Immovable Property (Land) -
2026-02-06 Board Meeting Outcome for Board Meeting Outcome For Meeting Held On 06Th February 2026 -
2026-01-26 Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-01-19 Statement On Redressal Of Investor Grievances/ Complaints For The Quarter Ended 31.12.2025 -
2026-01-07 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-12-28 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2025-12-27 Reg. 34 (1) Annual Report. -
2025-12-27 Announcement under Regulation 30 (LODR)-Change in Management -
2025-12-27 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2025-12-16 Corrigendum To Notice Of 8Th Annual General Meeting -